AU2021305247A1 - Posterior chamber delivery device for sustained release implant - Google Patents

Posterior chamber delivery device for sustained release implant Download PDF

Info

Publication number
AU2021305247A1
AU2021305247A1 AU2021305247A AU2021305247A AU2021305247A1 AU 2021305247 A1 AU2021305247 A1 AU 2021305247A1 AU 2021305247 A AU2021305247 A AU 2021305247A AU 2021305247 A AU2021305247 A AU 2021305247A AU 2021305247 A1 AU2021305247 A1 AU 2021305247A1
Authority
AU
Australia
Prior art keywords
implant
cannula
eye
lumen
bimatoprost
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021305247A
Other languages
English (en)
Inventor
David AUBUCHON
Alazar Ghebremeskel
Zoran Novakovic
Michael Robinson
John Vanden Dries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2021305247A1 publication Critical patent/AU2021305247A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2021305247A 2020-07-10 2021-07-09 Posterior chamber delivery device for sustained release implant Pending AU2021305247A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063050452P 2020-07-10 2020-07-10
US63/050,452 2020-07-10
US202163219440P 2021-07-08 2021-07-08
US63/219,440 2021-07-08
PCT/US2021/041189 WO2022011321A1 (en) 2020-07-10 2021-07-09 Posterior chamber delivery device for sustained release implant

Publications (1)

Publication Number Publication Date
AU2021305247A1 true AU2021305247A1 (en) 2023-02-23

Family

ID=77412324

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021305247A Pending AU2021305247A1 (en) 2020-07-10 2021-07-09 Posterior chamber delivery device for sustained release implant

Country Status (7)

Country Link
US (1) US20240024159A1 (cg-RX-API-DMAC7.html)
EP (1) EP4178506A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023534194A (cg-RX-API-DMAC7.html)
KR (1) KR20230035399A (cg-RX-API-DMAC7.html)
AU (1) AU2021305247A1 (cg-RX-API-DMAC7.html)
CA (1) CA3184833A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022011321A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1037439S1 (en) 2022-01-17 2024-07-30 EyePoint Pharamaceuticals, Inc. Ocular injector
CN114983670B (zh) * 2022-05-30 2025-08-01 海思盖德(苏州)生物医学科技有限公司 一种眼内植入物输送器
KR102792955B1 (ko) 2022-08-17 2025-04-17 주식회사 마이크로트 안구 내 튜브형 임플란트의 삽입장치
KR102849319B1 (ko) * 2024-01-09 2025-08-22 주식회사 마이크로트 심지 고정이 가능한 안질환용 임플란트의 삽입장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008070479A2 (en) 2006-12-01 2008-06-12 Allergan, Inc. Method for determining optimum intraocular locations for drug delivery systems
US9849027B2 (en) * 2007-11-08 2017-12-26 Alimera Sciences, Inc. Ocular implantation device
US8535333B2 (en) * 2009-07-29 2013-09-17 Transcend Medical, Inc. Ocular implant applier and methods of use
FR2979485B1 (fr) 2011-08-26 2016-09-09 E2V Semiconductors Capteur d'image a regroupement de pixels
EP4046628A1 (en) 2013-10-31 2022-08-24 Allergan, Inc. Prostamide-containing intraocular implants and methods of use thereof
CN106029019B (zh) * 2014-02-26 2020-07-03 阿勒根公司 眼内植入体递送设备及其使用方法
US11667405B2 (en) 2016-12-13 2023-06-06 8 Rivers Capital, Llc Vehicle launch system and method
US20190192341A1 (en) 2017-11-09 2019-06-27 Allergan, Inc. Sustained-Release Implants for Lowering Intraocular Pressure with Extended Duration of Effect

Also Published As

Publication number Publication date
EP4178506A1 (en) 2023-05-17
WO2022011321A1 (en) 2022-01-13
CA3184833A1 (en) 2022-01-13
KR20230035399A (ko) 2023-03-13
US20240024159A1 (en) 2024-01-25
JP2023534194A (ja) 2023-08-08

Similar Documents

Publication Publication Date Title
US20240065887A1 (en) Drug delivery implants as intraocular drug depots and methods of using same
US20240024159A1 (en) Posterior chamber placement of sustained release implant
TWI454285B (zh) 治療青光眼及高眼壓之活性劑之持續釋放輸送
CN103889401B (zh) 持续释放递送活性剂以治疗青光眼和高眼压
CN110302138B (zh) 含前列腺酰胺的眼内植入物及其使用方法
KR102322747B1 (ko) 프로스타마이드-함유 안구내 이식물
US20230011907A1 (en) Methods and apparatus for delivery of ocular implants
TW201012469A (en) Combination treatment of glaucoma
CN107405306A (zh) 眼部药物组合物
KR20160125456A (ko) 안구내 이식물 전달 장치 및 이의 사용 방법
KR20230042049A (ko) 높은 프로스타미드 로딩을 갖는 안구내 임플란트
HK1222810A1 (zh) 治疗开角型青光眼和高眼压症的药物递送系统和方法